Abstract
Ibrutinib (IMBRUVICA (R)), a small molecule inhibitor of Bruton's tyrosine kinase (BTK) developed by Pharmacyclics, Inc. and Janssen Pharmaceutical, i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
